Skip to content

Drug interactions

Darolutamide + Pitavastatin

Severity: Moderate

Darolutamide and Pitavastatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darolutamide inhibits the efflux transporter BCRP, which can raise systemic exposure to pitavastatin. Higher statin levels increase the likelihood of muscle toxicity such as myopathy.

What this interaction means in plain words

Darolutamide and Pitavastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Darolutamide belongs to Miscellaneous; Pitavastatin belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Inhibition of BCRP by darolutamide reduces efflux and increases pitavastatin exposure.

What to do

Monitor for muscle pain, weakness and CK elevation, and consider using the lowest effective pitavastatin dose. Switch to a statin that is not a BCRP substrate if symptoms develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darolutamide and Pitavastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darolutamide with Pitavastatin?

MediHelp rates the interaction as moderate. Darolutamide and Pitavastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Darolutamide inhibits the efflux transporter BCRP, which can raise systemic exposure to pitavastatin. Higher statin levels increase the likelihood of muscle toxicity such as myopathy.

How serious is the interaction between Darolutamide and Pitavastatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for muscle pain, weakness and CK elevation, and consider using the lowest effective pitavastatin dose. Switch to a statin that is not a BCRP substrate if symptoms develop.

What other medicines interact with Pitavastatin?

MediHelp also lists interactions of Pitavastatin with, for example, Cyclosporine, Cyclosporin, Erythromycin base. The full list is on the Pitavastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in